Literature DB >> 18491060

Scaffolding proteins at the postsynaptic density: shank as the architectural framework.

H-J Kreienkamp1.   

Abstract

Shank proteins are multidomain scaffold proteins of the postsynaptic density, connecting neurotransmitter receptors and other membrane proteins with signaling proteins and the actin cytoskeleton. By virtue of their protein interactions, Shank proteins assemble signaling platforms for G-protein-mediated signaling and the control of calcium homeostasis in dendritic spines. In addition, they participate in morphological changes, leading to maturation of dendritic spines and synapse formation. The importance of the Shank scaffolding function is demonstrated by genetically determined forms of mental retardation, which may be caused by haploinsufficiency for the SHANK3 gene. Consistent with its central function within the postsynaptic density, the availability of Shank is tightly controlled by local synthesis and degradation, as well as actin-dependent dynamic rearrangements within the dendritic spine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491060     DOI: 10.1007/978-3-540-72843-6_15

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  42 in total

Review 1.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

2.  Shank3-Rich2 interaction regulates AMPA receptor recycling and synaptic long-term potentiation.

Authors:  Fabrice Raynaud; Andrea Janossy; Janine Dahl; Federica Bertaso; Julie Perroy; Annie Varrault; Michel Vidal; Paul F Worley; Tobias M Boeckers; Joël Bockaert; Philippe Marin; Laurent Fagni; Vincent Homburger
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

Review 3.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

Review 4.  IGSF9 family proteins.

Authors:  Maria Hansen; Peter Schledermann Walmod
Journal:  Neurochem Res       Date:  2013-02-16       Impact factor: 3.996

5.  Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength.

Authors:  Magali H Arons; Kevin Lee; Charlotte J Thynne; Sally A Kim; Claudia Schob; Stefan Kindler; Johanna M Montgomery; Craig C Garner
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

Review 6.  Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.

Authors:  Jesse L Costales; Alexander Kolevzon
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 7.  Modeling autism by SHANK gene mutations in mice.

Authors:  Yong-Hui Jiang; Michael D Ehlers
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

8.  Effects of curcumin on synapses in APPswe/PS1dE9 mice.

Authors:  Yingkun He; Pengwen Wang; Peng Wei; Huili Feng; Ying Ren; Jinduo Yang; Yingxue Rao; Jing Shi; Jinzhou Tian
Journal:  Int J Immunopathol Pharmacol       Date:  2016-03-08       Impact factor: 3.219

Review 9.  Therapeutic approaches for shankopathies.

Authors:  Xiaoming Wang; Alexandra L Bey; Leeyup Chung; Andrew D Krystal; Yong-Hui Jiang
Journal:  Dev Neurobiol       Date:  2013-10-11       Impact factor: 3.964

10.  The backbone of the post-synaptic density originated in a unicellular ancestor of choanoflagellates and metazoans.

Authors:  Alexandre Alié; Michaël Manuel
Journal:  BMC Evol Biol       Date:  2010-02-03       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.